Cargando…

Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN

BACKGROUND: Cardiovascular disease (CVD) in women has unique features, including associations with reproductive factors that are incompletely understood. Vasomotor symptoms (VMS), the classic menopausal symptom, are linked to CVD risk factors and subclinical CVD. Evidence linking VMS to CVD events i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thurston, Rebecca C., Aslanidou Vlachos, Helen E., Derby, Carol A., Jackson, Elizabeth A., Brooks, Maria Mori, Matthews, Karen A., Harlow, Sioban, Joffe, Hadine, El Khoudary, Samar R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955448/ https://www.ncbi.nlm.nih.gov/pubmed/33470142 http://dx.doi.org/10.1161/JAHA.120.017416

Ejemplares similares

Vasomotor symptoms in midlife women with incident breast cancer: pink SWAN
por: Gold, Ellen B., et al.
Publicado: (2021)

Age at Menopause in Relationship to Lipid Changes and Subclinical Carotid Disease Across 20 Years: Study of Women's Health Across the Nation
por: Matthews, Karen A., et al.
Publicado: (2021)

Interpersonal Trauma and Risk of Incident Cardiovascular Disease Events Among Women
por: Thurston, Rebecca C., et al.
Publicado: (2022)

The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)
por: El Khoudary, Samar R., et al.
Publicado: (2019)

Cardiovascular Disease Risk Factor Burden During the Menopause Transition and Late Midlife Subclinical Vascular Disease: Does Race/Ethnicity Matter?
por: Barinas‐Mitchell, Emma, et al.
Publicado: (2020)

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause
por: Pinkerton, JoAnn V., et al.
Publicado: (2015)

SYSTEMATIC EXCLUSION AT STUDY COMMENCEMENT MASKS EARLIER MENOPAUSE FOR BLACK WOMEN IN THE STUDY OF WOMEN’S HEALTH ACROSS THE NATION (SWAN)
por: Reeves, Alexis, et al.
Publicado: (2022)

History of Adverse Pregnancy Outcomes, Blood Pressure, and Subclinical Vascular Measures in Late Midlife: SWAN (Study of Women's Health Across the Nation)
por: Cortés, Yamnia I., et al.
Publicado: (2017)

Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN)
por: Jackson, Elizabeth A., et al.
Publicado: (2017)

Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms
por: Yang, Yihui, et al.
Publicado: (2023)

Association of Menopausal Vasomotor Symptoms With Increased Bone Turnover During the Menopausal Transition
por: Crandall, Carolyn J, et al.
Publicado: (2011)

Urinary metals and incident diabetes in midlife women: Study of Women’s Health Across the Nation (SWAN)
por: Wang, Xin, et al.
Publicado: (2020)

Women’s Midlife Health: Why the Midlife Matters
por: Harlow, Siobán D., et al.
Publicado: (2015)

Body Mass Index Following Natural Menopause and Hysterectomy with and without Bilateral Oophorectomy
por: Gibson, Carolyn J., et al.
Publicado: (2012)

Is race or ethnicity associated with under‐utilization of statins among women in the United States: The study of women's health across the nation
por: Jackson, Elizabeth A., et al.
Publicado: (2020)

Carotid Intima Media Thickness and Comorbid Cardiometabolic Dysfunction in Women: The SWAN Study
por: Leis, Aleda, et al.
Publicado: (2021)

Adipokines and Subclinical Cardiovascular Disease in Post‐Menopausal Women: Study of Women's Health Across the Nation
por: Everson‐Rose, Susan A., et al.
Publicado: (2021)

Early Midlife Cardiovascular Health Influences Future HDL Metrics in Women: The SWAN HDL Study
por: Nasr, Alexis, et al.
Publicado: (2022)

OR11-03 NT-814, a Non-Hormonal Dual Neurokinin 1,3 Receptor Antagonist Markedly Improves Vasomotor Symptoms in Post-Menopausal Women; Results of a Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Study (SWITCH-1)
por: Simon, James, et al.
Publicado: (2020)

Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial
por: Trower, Mike, et al.
Publicado: (2020)

THE STUDY OF WOMEN’S HEALTH ACROSS THE NATION (SWAN): FROM MIDLIFE ONWARD
por: Avis, Nancy E, et al.
Publicado: (2019)

Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action
por: Abdi, Fatemeh, et al.
Publicado: (2016)

Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study
por: Solomon, Daniel H, et al.
Publicado: (2021)

STAIR CLIMB TIME AND FUNCTIONAL POWER ASSOCIATIONS IN EARLY OLD AGE: SWAN
por: Strotmeyer, Elsa, et al.
Publicado: (2019)

Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms, an appraisal
por: Gompel, Anne, et al.
Publicado: (2023)

Perceived stress across the midlife: longitudinal changes among a diverse sample of women, the Study of Women’s health Across the Nation (SWAN)
por: Hedgeman, Elizabeth, et al.
Publicado: (2018)

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
por: Umland, Elena M, et al.
Publicado: (2012)

Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms
por: Singhal, Savita Rani, et al.
Publicado: (2016)

Vasomotor and physical menopausal symptoms are associated with sleep quality
por: Kim, Min-Ju, et al.
Publicado: (2018)

Psychosomatic and vasomotor symptom changes during transition to menopause
por: Augoulea, Areti, et al.
Publicado: (2019)

MON-387 Pheochromocytoma Masquerading as Vasomotor Menopausal Symptoms
por: Xhikola, Majlinda, et al.
Publicado: (2019)

Vasomotor Symptoms: More Than Temporary Menopausal Symptoms
por: Ryu, Ki-Jin, et al.
Publicado: (2020)

Liver fat and SHBG affect insulin resistance in midlife women: The Study of Women’s Health Across the Nation (SWAN)
por: Kavanagh, Kylie, et al.
Publicado: (2013)

Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT
por: Johnson, Kimball A, et al.
Publicado: (2023)

Comparing polysomnography, actigraphy, and sleep diary in the home environment: The Study of Women’s Health Across the Nation (SWAN) Sleep Study
por: Lehrer, H Matthew, et al.
Publicado: (2022)

Healthy Lifestyle During the Midlife Is Prospectively Associated With Less Subclinical Carotid Atherosclerosis: The Study of Women's Health Across the Nation
por: Wang, Dongqing, et al.
Publicado: (2018)

Postmenopausal Women With Greater Paracardial Fat Have More Coronary Artery Calcification Than Premenopausal Women: The Study of Women's Health Across the Nation (SWAN) Cardiovascular Fat Ancillary Study
por: El Khoudary, Samar R., et al.
Publicado: (2017)

Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
por: Pinkerton, JoAnn V, et al.
Publicado: (2023)

Treatment Strategies for Reducing the Burden of Menopause-Associated Vasomotor Symptoms
por: Umland, Elena M.
Publicado: (2008)

Disparities in Reproductive Aging and Midlife Health between Black and White women: The Study of Women’s Health Across the Nation (SWAN)
por: Harlow, Siobán D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uk3lfregplfeo8bh44lb6covk9